Literature DB >> 33245914

Challenges in the Development, Deployment, and Regulation of Artificial Intelligence in Anatomic Pathology.

Jerome Y Cheng1, Jacob T Abel2, Ulysses G J Balis2, David S McClintock2, Liron Pantanowitz2.   

Abstract

Significant advances in artificial intelligence (AI), deep learning, and other machine-learning approaches have been made in recent years, with applications found in almost every industry, including health care. AI has proved to be capable of completing a spectrum of mundane to complex medically oriented tasks previously performed only by boarded physicians, most recently assisting with the detection of cancers difficult to find on histopathology slides. Although computers will not replace pathologists any time soon, properly designed AI-based tools hold great potential for increasing workflow efficiency and diagnostic accuracy in the practice of pathology. Recent trends, such as data augmentation, crowdsourcing for generating annotated data sets, and unsupervised learning with molecular and/or clinical outcomes versus human diagnoses as a source of ground truth, are eliminating the direct role of pathologists in algorithm development. Proper integration of AI-based systems into anatomic-pathology practice will necessarily require fully digital imaging platforms, an overhaul of legacy information-technology infrastructures, modification of laboratory/pathologist workflows, appropriate reimbursement/cost-offsetting models, and ultimately, the active participation of pathologists to encourage buy-in and oversight. Regulations tailored to the nature and limitations of AI are currently in development and, when instituted, are expected to promote safe and effective use. This review addresses the challenges in AI development, deployment, and regulation to be overcome prior to its widespread adoption in anatomic pathology.
Copyright © 2020 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 33245914     DOI: 10.1016/j.ajpath.2020.10.018

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  4 in total

1.  Automated bone marrow cytology using deep learning to generate a histogram of cell types.

Authors:  Rohollah Moosavi Tayebi; Youqing Mu; Taher Dehkharghanian; Catherine Ross; Monalisa Sur; Ronan Foley; Hamid R Tizhoosh; Clinton J V Campbell
Journal:  Commun Med (Lond)       Date:  2022-04-20

Review 2.  Ki-67 assessment of pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis of manual vs. digital pathology scoring.

Authors:  Claudio Luchini; Liron Pantanowitz; Volkan Adsay; Sylvia L Asa; Pietro Antonini; Ilaria Girolami; Nicola Veronese; Alessia Nottegar; Sara Cingarlini; Luca Landoni; Lodewijk A Brosens; Anna V Verschuur; Paola Mattiolo; Antonio Pea; Andrea Mafficini; Michele Milella; Muhammad K Niazi; Metin N Gurcan; Albino Eccher; Ian A Cree; Aldo Scarpa
Journal:  Mod Pathol       Date:  2022-03-05       Impact factor: 8.209

3.  Research trends of artificial intelligence in pancreatic cancer: a bibliometric analysis.

Authors:  Hua Yin; Feixiong Zhang; Xiaoli Yang; Xiangkun Meng; Yu Miao; Muhammad Saad Noor Hussain; Li Yang; Zhaoshen Li
Journal:  Front Oncol       Date:  2022-08-02       Impact factor: 5.738

Review 4.  Artificial intelligence for renal cancer: From imaging to histology and beyond.

Authors:  Karl-Friedrich Kowalewski; Luisa Egen; Chanel E Fischetti; Stefano Puliatti; Gomez Rivas Juan; Mark Taratkin; Rivero Belenchon Ines; Marie Angela Sidoti Abate; Julia Mühlbauer; Frederik Wessels; Enrico Checcucci; Giovanni Cacciamani
Journal:  Asian J Urol       Date:  2022-06-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.